Financial Data and Key Metrics Changes - Consolidated net sales for Q2 FY 2025 increased by 12.1% to 44.1 million in Q2 FY 2024, marking the second consecutive quarterly year-over-year increase in sales [8][9] - Gross margin improved to 31% of net sales from 28.4% in the prior year, with significant margin expansion across most business segments [9][10] - Net loss for Q2 FY 2025 was 0.05 per diluted share, compared to a net loss of 0.13 per diluted share in Q2 FY 2024 [11] Business Line Data and Key Metrics Changes - Green Energy Solutions (GES) sales grew by 129% to 34.4 million, driven by higher sales to semiconductor wafer fab customers [9][24] - Healthcare sales declined by 22.8% to 6.9 million, impacted by lower sales in European markets, particularly due to economic challenges [38] Company Strategy and Development Direction - The company is focused on a multiyear growth strategy, particularly in the green energy sector, with a strong emphasis on power management applications [22][47] - There is a commitment to expanding global technology partnerships to enhance product offerings and capture more revenue [26][27] - The company is investing in infrastructure and talent to support growth, including hiring design and field engineers [28] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing a strong backlog and numerous new product introductions [18] - The semiconductor wafer fab market is expected to see sustained growth due to rising demand driven by AI and 5G deployment [48] - Despite uncertainties in the global environment, the company remains committed to its long-term growth strategies [47] Other Important Information - Cash and cash equivalents at the end of Q2 FY 2025 were 23.0 million at the end of Q1 FY 2025 [14] - The company declared a regular quarterly cash dividend of 0.06 per common share, to be paid in Q3 FY 2025 [15] Q&A Session Summary Question: What is the expected shipping timeframe for recent multimillion orders? - The company has already started shipping, with the balance expected to ship throughout calendar year 2025 [56] Question: Can you provide more details on new program wins? - New program wins primarily occurred with wind turbine applications, contributing to market share growth [74][78] Question: What is the outlook for SG&A expenses? - SG&A expenses are expected to increase in line with sales growth but not at the same rate as seen in Q2 [81] Question: Can you provide an update on the shipping timeline for diesel locomotive products? - Major shipments are expected at the end of Q3, with ongoing shipments throughout 2025 [91] Question: What is the current balance of Thales-related inventory? - The current balance is around 30 million, with expectations for it to deplete as products are sold [148] Question: What is the status of the healthcare business unit? - The healthcare division is still losing money but is seeing improvements in gross margin and factory absorption [126]
Richardson Electronics(RELL) - 2025 Q2 - Earnings Call Transcript